SPONSORED CONTENT
TIP: Use quarterly eRx data analysis to identify contract pharmacy expansion opportunities, including independent pharmacies.
Every quarter,
Blog Posts
Oregon state senators late yesterday narrowly passed legislation to prohibit drugmakers from restricting 340B contract pharmacy access in the state. [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Trump administration this month urged a Washington D.C. federal court to uphold a 2013 Health Resources and Services Administration [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
An Indiana congresswoman recently introduced a controversial U.S. House bill that could potentially require 340B covered entities to pass all [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
It’s easy to remember the days before 340B ESP, when setting up of a wholesale account was an easy and streamlined process. The Health Industry Number (HIN) was not something that was discussed very often prior to the manufacturer restrictions. The HIN is
…
The Vermont House on Friday approved a 340B contract pharmacy access bill with Senate-backed hospital reporting requirements and a new [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Oregon state senators are pushing for competing amendments to a 340B contract pharmacy access bill that passed the state House; [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
AstraZeneca and the brand-name drug industry’s leading trade group have filed federal lawsuits challenging newly enacted 340B contract pharmacy access [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two Oklahoma Republican lawmakers are urging their colleagues to override Gov. Kevin Stitt’s (R) veto of a 340B contract pharmacy [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Following a string of losses in federal courts, some drugmakers are now turning to state-level courts in an effort to [...] …